Brian Robert Braaksma, MD Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Accepting Medicare Assignments Practice Location: 3025 N Tarrant Pkwy Ste 220, Ft Worth, TX 76177 Phone: 817-898-6688 Fax: 817-562-8313 |
Dr. Adewale Oluwaseun Adeniran, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1650 W Rosedale St Ste 301, Ft Worth, TX 76104 Phone: 682-610-5670 Fax: 817-348-0087 |
Iyooh Uchechuwu Davidson, M.D Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Accepting Medicare Assignments Practice Location: 1650 W Rosedale St Ste 301, Ft Worth, TX 76104 Phone: 682-610-5670 Fax: 817-348-0087 |
Jonathan Guevara, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5612 Edwards Ranch Rd, Ft Worth, TX 76109 Phone: 817-420-9238 Fax: 817-570-0182 |
Derek George Dombroski, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 800 5th Ave, Suite 500, Ft Worth, TX 76104 Phone: 817-878-5300 Fax: 817-878-5321 |
News Archive
The body mass index (BMI) of individuals who drink alcohol may be related to how much, and how often, they drink, according to a new study by researchers at the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
Scientists from the U.S. Food and Drug Administration (FDA) have identified a benign bacterium that shows promise in blocking Salmonella from colonizing raw tomatoes.
Medical Marijuana, Inc. is the ONLY company that provides the specific solutions the government is seeking in order for all collectives and co-ops to be in total compliance with state laws and city/county ordinances. Their revolutionary patent pending Tax Remittance Card and patent pending Inventory Management System and Supply Chain Network provides all of the tools necessary for regulatory authorities and industry operators alike to manage compliance efficiently and effectively.
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced financial results for the three and six months ended June 30, 2010.
› Verified 3 days ago